D-11-1580

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameD-11-1580
Drug Alias NameCCR2B antagonists (Daiichi)D-11-1580
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 2 antagonists
TargetsC-C chemokine receptor type 2
Therapy Area/IndicationsInflammationAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Seiyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaiichi Seiyaku Co Ltd
Active IndicationsN/A
Inactive IndicationsInflammationAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A